Interestingly, anti-myeloma treatment seems to restore bone metabolism [95,96,97,98,99], whereas anti-resorptive treatment such as bisphosphonates and anti-RANKL agents reverse myeloma-induced hypercalcemia [90,96]. This evidence concerns the gene TNFSF11 and plasma cell myeloma.